{
  "abstract": "Prostate cancer progression is strongly influenced by the tumor immune microenvironment, in which M2-like tumor-associated macrophages (TAMs) promote immune suppression and tumor growth. Although TAM-targeted therapies have emerged as promising immunomodulatory strategies, the downstream immune effector mechanisms associated with tumor suppression after M2-like TAM targeting remain incompletely defined. Here, we investigated whether TB511, an M2-like TAM-targeting peptide-drug conjugate, suppresses prostate tumor growth by remodeling the M2-like TAM compartment and promoting NK cell-associated antitumor immunity. TIMER3.0 analysis of human prostate adenocarcinoma datasets showed increased expression of M2-like TAM-associated genes and reduced expression of several NK cell-associated genes in tumor tissues compared with normal prostate tissues. In immunocompetent TRAMP-C2 and RM-1 syngeneic prostate cancer models, TB511 significantly reduced tumor growth and tumor burden. TB511 selectively decreased F4/80+CD206+ M2-like macrophages without significantly reducing F4/80+CD86+ M1-like macrophages, increased the M1/M2 macrophage ratio, and suppressed M2-associated immunosuppressive genes, including ARG1, CD163, TGFB, and IL10. TB511 also increased CD8+ T-cell and NK cell infiltration, enhanced NCR1-positive cells, increased GZMB-expressing NK-associated cytotoxic cells, increased NK-associated effector genes, and decreased the inhibitory receptor-associated genes NKG2A and TIGIT. In contrast, TB511 failed to suppress TRAMP-C2 tumor growth in immunodeficient NSG mice, supporting an immune-dependent component of its antitumor activity. Immune cell depletion experiments further revealed that CD8 T-cell depletion did not abolish TB511-mediated tumor suppression, whereas NK1.1+ cell depletion eliminated the antitumor effect of TB511. Notably, TB511 still reduced M2-like macrophages under NK1.1+ cell-depleted conditions, indicating that macrophage remodeling alone is insufficient for tumor control without NK1.1+ cells. These findings demonstrate that TB511 suppresses prostate tumor growth by selectively reducing M2-like TAMs and promoting NK cell-associated cytotoxic antitumor immunity, with NK1.1+ cells required for therapeutic efficacy. TB511 may represent a promising immunomodulatory peptide-drug conjugate for targeting the M2-like TAM-NK cell axis in prostate cancer.",
  "abstract_shown": true,
  "affiliations": [],
  "article_type": "Original Research",
  "arxiv": null,
  "author_total": 5,
  "authors": [
    {
      "name": "Ik-Hwan Han"
    },
    {
      "name": "DaeHwan Park"
    },
    {
      "name": "Jihwan Moon"
    },
    {
      "name": "Chaeyoung Kwon"
    },
    {
      "name": "Hyunsu Bae"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/f1ej0s2zpecjz.bib",
  "cited_by": 0,
  "doi": "10.3389/fimmu.2026.1938334",
  "fulltext_url": null,
  "id": "f1ej0s2zpecjz",
  "issns": [
    "1664-3224"
  ],
  "landing_url": "https://www.frontiersin.org/articles/10.3389/fimmu.2026.1938334",
  "language": null,
  "licence": "CC-BY-4.0",
  "licence_label": "CC BY 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "feed-journal",
      "biology/immunology"
    ]
  ],
  "openalex": null,
  "pdf_url": null,
  "pmcid": null,
  "pmid": null,
  "published": "2026-11-10",
  "publisher": "Frontiers Media SA",
  "ris": "https://research.draconitic.com/paper/f1ej0s2zpecjz.ris",
  "sources": [
    {
      "first_seen": "2026-11-10T12:20:56Z",
      "native_id": "10.3389/fimmu.2026.1938334",
      "source": "feed-frontiers",
      "url": "https://www.frontiersin.org/articles/10.3389/fimmu.2026.1938334"
    },
    {
      "first_seen": "2026-11-10T12:23:11Z",
      "native_id": "10.3389/fimmu.2026.1938334",
      "source": "crossref",
      "url": "https://www.frontiersin.org/articles/10.3389/fimmu.2026.1938334/full"
    }
  ],
  "subjects": [
    {
      "field": "biology",
      "origin": "feed-journal:biology/immunology",
      "subfield": "immunology"
    }
  ],
  "title": "Selective targeting of M2-like tumor-associated macrophages by TB511 promotes NK cell-associated antitumor immunity in prostate cancer",
  "title_text": "Selective targeting of M2-like tumor-associated macrophages by TB511 promotes NK cell-associated antitumor immunity in prostate cancer",
  "type": "peer-reviewed",
  "updated_at": "2026-11-12T00:20:49Z",
  "url": "https://research.draconitic.com/paper/f1ej0s2zpecjz",
  "venue": "Frontiers in Immunology",
  "versions": []
}